TD Cowen analysts evaluated the Strategy’s (MSTR) treasury activity against bitcoin (BTC) trading volume and price action ...

TD Cowen upgraded Fidelity National Information Services (NASDAQ:III) to “Buy” from “Hold” raising its price target to $92 from $80 driven by company’s shift toward a more stable and transparent ...

The number of tech giants paring back on their AI data center plans rises to two. According to banks Wells Fargo and TD Cowen ...

Inc. to Hold from Buy and slashed its price target to $78 from $110, warning that the company’s planned acquisition of Worldpay undermines efforts to streamline operations and introduces ...

While pricing improved for LTL and truckload rates in Q1, tariffs seem to be clouding the long-term outlook, according to the ...

MicroStrategy stock rose Monday after the software company revealed it had snapped up even more Bitcoin. It’s hardly news for ...

The perceived favorite to replace Jerome Powell at the Fed, whenever that happens, is former Fed governor Kevin Warsh, who ...

Wall Street analysts anticipate Netflix will report strong Q1 2025 earnings and say the company is positioned to withstand an ...

Netflix (NASDAQ:NFLX) climbed about 2% to $973 following its robust first-quarter earnings report released April 17, which ...

The S&P 500 Index ( $SPX) ( SPY) Monday closed down -2.36%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) closed down -2.48%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) closed down -2.46%. June ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price ...

Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.